跳至主要内容
临床试验/EUCTR2018-003381-14-SE
EUCTR2018-003381-14-SE进行中(未招募)1 期

Budesonide versus Prednisolone as Primary Treatment for AutoimmuneHepatitis: An Open-label, Randomized, Prospective Multicenter 12-monthClinical Trial Evaluating Effect and Side-Effects. - AIHBUDPRED

meå University Hospital0 个研究点目标入组 150 人开始时间: 2019年12月11日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. A written informed consent is signed before any study-related
  • procedures are performed.
  • 2. Male and female subjects aged =18 years of age.
  • 3. A definitive diagnosis of autoimmune hepatitis with a score of =6
  • according to the simplified AIH criteria.
  • 4. A liver biopsy should, a) have been performed within the last 6
  • months, and, b) show interface inflammation grade of =1 according to
  • the Ludwig-Batts grading scale.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 145
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • 1. Chronic liver disease other than AIH (PBC, PSC, viral hepatitis,
  • hemochromatosis, homozygous alpha-1-antitrypsin deficiency and
  • Wilson disease)
  • 2. Ongoing immune-modulating therapy
  • 3. Liver cirrhosis/fibrosis grade 4 according to Ludwig-Batts grading
  • scale and/or clinically compensated or decompensated liver cirrhosis
  • (signs of portal hypertension and/or cirrhosis on radiology, ultrasound
  • 4. Current malignancy
  • 5. Alcohol overconsumption (B-PEth >0.3 µmol/L)
  • 6. Contraindication to corticosteroids
  • 7. Contraindication to azathioprine
  • 8. Suggested non-compliance with the protocol.
  • 9. Pregnancy or breast-feeding

研究者

发起方
meå University Hospital

相似试验